B.C. biotech company AbCellera Biologics goes public, shares surge 170% on Nasdaq

日本 ニュース ニュース

B.C. biotech company AbCellera Biologics goes public, shares surge 170% on Nasdaq
日本 最新ニュース,日本 見出し

AbCellera says the IPO will raise US$483 million for its business, which analyzes the immune system to help drug developers treat diseases.

The company’s top investors include board member Peter Thiel, a co-founder of PayPal and early investor in Facebook.

AbCellera announced last month it was working with Eli Lilly to develop a treatment for COVID-19, and that its Phase 2 clinical data had received interim authorization by Health Canada.Share this article in your social network

 

日本 最新ニュース, 日本 見出し



Render Time: 2025-01-09 15:02:49